Purdue Pharma, the makers and marketers of the highly addictive opioid OxyContin, and the family that owned the company, the Sackler family, have agreed to pay $7.4 billion to individuals ...

Purdue Pharma, the makers and marketers of the highly addictive opioid OxyContin, and the family that owned the company, the Sackler family, have agreed to pay $7.4 billion to individuals, states, ...

Lively "has made clear" that she "does not want Mr. Freedman to be the attorney who takes her deposition," Baldoni's lawyer Kevin Fritz alleged in a letter Gotham/WireImage (2) Kevin Fritz ...

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the now-bankrupt Purdue Pharma, the Sacklers, has come back from last year’s ...

This month’s KELOLAND Living Book Club selection examines the history of the Sackler family, including the founding of Purdue Pharma, its role in the marketing of pharmaceuticals, and the family ...

Jan 13 (Reuters) - The Sackler family owners of Purdue Pharma are offering to increase their financial contribution to a bankruptcy settlement of opioid lawsuits, while agreeing to some exposure ...

Colorado is set to receive around $81 million from a $7.4 billion preliminary settlement with Purdue Pharma, the company’s owners and members of the Sackler family for their role in the opioid ...

HARRISBURG — Pennsylvania stands to receive up to $212 million paid out by the family and firm behind the nationwide saturation of OxyContin as part of the latest legal settlement stemming from ...

The wheels of justice can grind slowly, especially when large amounts of money are involved, but justice of some sort is being done. As reported by the Associated Press on Thursday, members of the ...

Purdue Pharma’s Sackler family owners are offering to increase their financial contribution to a bankruptcy settlement of opioid lawsuits while accepting some exposure to future litigation ...

Purdue Pharma and its controlling Sackler family have offered a new settlement to resolve lawsuits over their involvement in the opioid epidemic, raising the payout from the Sacklers to $6 billion.